Differential trafficking of TLR1 I602S underlies host protection against pathogenic mycobacteria

Journal of Immunology

Volumn 189, Issue 11, 2012, Pages 5347-5355

  Hart, Bryan E ^a   Tapping, Richard I ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; ARGININE; CD64 ANTIGEN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; REACTIVE NITROGEN SPECIES; TOLL LIKE RECEPTOR 10;

ARTICLE; BACTERIAL CELL; CELL ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HOMOZYGOSITY; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MACROPHAGE; MICROSCOPY; MONOCYTE; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN DEPLETION;

ARGINASE; CELL MEMBRANE; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERFERON-GAMMA; ISOLEUCINE; MACROPHAGES; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TRANSPORT; RECEPTORS, IGG; SERINE; TOLL-LIKE RECEPTOR 1;

EID: 84869843022     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201545     Document Type: Article

References (62)

1. Gupta, A., A. Kaul, A. G. Tsolaki, U. Kishore, and S. Bhakta. 2012. Mycobacterium tuberculosis: immune evasion, latency and reactivation. Immunobiology 217: 363-374.
2. Baena, A., and S. A. Porcelli. 2009. Evasion and subversion of antigen presentation by Mycobacterium tuberculosis. Tissue Antigens 74: 189-204.
3. World Health Organization. 2011. Leprosy update, 2011. Wkly. Epidemiol. Rec. 86: 389-399.
4. Kleinnijenhuis, J., M. Oosting, L. A. Joosten, M. G. Netea, and R. Van Crevel. 2011. Innate immune recognition of Mycobacterium tuberculosis. Clin. Dev. Immunol. 2011: 405310.
5. Tsolaki, A. G. 2009. Innate immune recognition in tuberculosis infection. Adv. Exp. Med. Biol. 653: 185-197.
6. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801. (Pubitemid 43261452)
7. Aliprantis, A. O., R. B. Yang, M. R. Mark, S. Suggett, B. Devaux, J. D. Radolf, G. R. Klimpel, P. Godowski, and A. Zychlinsky. 1999. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285: 736-739.
8. Brightbill, H. D., D. H. Libraty, S. R. Krutzik, R. B. Yang, J. T. Belisle, J. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, et al. 1999. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285: 732-736.
9. Drage, M. G., N. D. Pecora, A. G. Hise, M. Febbraio, R. L. Silverstein, D. T. Golenbock, W. H. Boom, and C. V. Harding. 2009. TLR2 and its coreceptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis. Cell. Immunol. 258: 29-37.
10. Krutzik, S. R., M. T. Ochoa, P. A. Sieling, S. Uematsu, Y. W. Ng, A. Legaspi, P. T. Liu, S. T. Cole, P. J. Godowski, Y. Maeda, et al. 2003. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat. Med. 9: 525-532. (Pubitemid 36597097)
11. Means, T. K., S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock, and M. J. Fenton. 1999. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163: 3920-3927. (Pubitemid 29450920)
12. Takeuchi, O., S. Sato, T. Horiuchi, K. Hoshino, K. Takeda, Z. Dong, R. L. Modlin, and S. Akira. 2002. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169: 10-14. (Pubitemid 34686113)
13. Tapping, R. I., and P. S. Tobias. 2003. Mycobacterial lipoarabinomannan mediates physical interactions between TLR1 and TLR2 to induce signaling. J. Endotoxin Res. 9: 264-268. (Pubitemid 36874538)
14. Underhill, D. M., A. Ozinsky, A. M. Hajjar, A. Stevens, C. B. Wilson, M. Bassetti, and A. Aderem. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401: 811-815.
15. Hart, B. E., and R. I. Tapping. 2012. Genetic Diversity of Toll-Like Receptors and Immunity to M. leprae Infection. J. Trop. Med. 2012: 415057.
16. Schumann, R. R., and R. I. Tapping. 2007. Genomic variants of TLR1 - it takes (TLR-)two to tango. Eur. J. Immunol. 37: 2059-2062. (Pubitemid 47250197)
17. Johnson, C. M., E. A. Lyle, K. O. Omueti, V. A. Stepensky, O. Yegin, E. Alpsoy, L. Hamann, R. R. Schumann, and R. I. Tapping. 2007. Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J. Immunol. 178: 7520-7524. (Pubitemid 46898019)
18. Hawn, T. R., E. A. Misch, S. J. Dunstan, G. E. Thwaites, N. T. Lan, H. T. Quy, T. T. Chau, S. Rodrigues, A. Nachman, M. Janer, et al. 2007. A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur. J. Immunol. 37: 2280-2289. (Pubitemid 47250219)
19. Ma, X., Y. Liu, B. B. Gowen, E. A. Graviss, A. G. Clark, and J. M. Musser. 2007. Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS ONE 2: e1318.
20. Misch, E. A., M. Macdonald, C. Ranjit, B. R. Sapkota, R. D. Wells, M. R. Siddiqui, G. Kaplan, and T. R. Hawn. 2008. Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction. PLoS Negl. Trop. Dis. 2: e231.
21. Wong, S. H., S. Gochhait, D. Malhotra, F. H. Pettersson, Y. Y. Teo, C. C. Khor, A. Rautanen, S. J. Chapman, T. C. Mills, A. Srivastava, et al. 2010. Leprosy and the adaptation of human toll-like receptor 1. PLoS Pathog. 6: e1000979.
22. Hart, B. E. and R. I. Tapping. 2012. Cell surface trafficking of TLR1 is differentially regulated by the ER chaperones PRAT4A and PRAT4B. J. Biol. Chem. 287: 16550-16562.
23. Banaiee, N., E. Z. Kincaid, U. Buchwald, W. R. Jacobs, Jr., and J. D. Ernst. 2006. Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2. J. Immunol. 176: 3019-3027.
24. Fortune, S. M., A. Solache, A. Jaeger, P. J. Hill, J. T. Belisle, B. R. Bloom, E. J. Rubin, and J. D. Ernst. 2004. Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms. J. Immunol. 172: 6272-6280. (Pubitemid 38621234)
25. Gehring, A. J., R. E. Rojas, D. H. Canaday, D. L. Lakey, C. V. Harding, and W. H. Boom. 2003. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2. Infect. Immun. 71: 4487-4497. (Pubitemid 36919915)
26. Kincaid, E. Z., A. J. Wolf, L. Desvignes, S. Mahapatra, D. C. Crick, P. J. Brennan, M. S. Pavelka, Jr., and J. D. Ernst. 2007. Codominance of TLR2-dependent and TLR2-independent modulation of MHC class II in Mycobacterium tuberculosis infection in vivo. J. Immunol. 179: 3187-3195.
27. Kumar, P., R. Agarwal, I. Siddiqui, H. Vora, G. Das, and P. Sharma. 2012. ESAT6 differentially inhibits IFN-g-inducible class II transactivator isoforms in both a TLR2-dependent and -independent manner. Immunol. Cell Biol. 90: 411-420.
28. Lafuse, W. P., G. R. Alvarez, H. M. Curry, and B. S. Zwilling. 2006. Mycobacterium tuberculosis and Mycobacterium avium inhibit IFN-gamma-induced gene expression by TLR2-dependent and independent pathways. J. Interferon Cytokine Res. 26: 548-561. (Pubitemid 44289897)
29. López, M., L. M. Sly, Y. Luu, D. Young, H. Cooper, and N. E. Reiner. 2003. The 19-kDa Mycobacterium tuberculosis protein induces macrophage apoptosis through Toll-like receptor-2. J. Immunol. 170: 2409-2416. (Pubitemid 36245628)
30. Noss, E. H., R. K. Pai, T. J. Sellati, J. D. Radolf, J. Belisle, D. T. Golenbock, W. H. Boom, and C. V. Harding. 2001. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J. Immunol. 167: 910-918. (Pubitemid 32660847)
31. Pai, R. K., M. Convery, T. A. Hamilton, W. H. Boom, and C. V. Harding. 2003. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. J. Immunol. 171: 175-184. (Pubitemid 36745286)
32. Pai, R. K., M. E. Pennini, A. A. Tobian, D. H. Canaday, W. H. Boom, and C. V. Harding. 2004. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages. Infect. Immun. 72: 6603-6614. (Pubitemid 39425443)
33. Pathak, S. K., S. Basu, K. K. Basu, A. Banerjee, S. Pathak, A. Bhattacharyya, T. Kaisho, M. Kundu, and J. Basu. 2007. Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat. Immunol. 8: 610-618. (Pubitemid 46785125)
34. Pennini, M. E., R. K. Pai, D. C. Schultz, W. H. Boom, and C. V. Harding. 2006. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling. J. Immunol. 176: 4323-4330. (Pubitemid 44264411)
35. Prados-Rosales, R., A. Baena, L. R. Martinez, J. Luque-Garcia, R. Kalscheuer, U. Veeraraghavan, C. Camara, J. D. Nosanchuk, G. S. Besra, B. Chen, et al. 2011. Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. J. Clin. Invest. 121: 1471-1483.
36. Ting, L. M., A. C. Kim, A. Cattamanchi, and J. D. Ernst. 1999. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. J. Immunol. 163: 3898-3906. (Pubitemid 29450917)
37. Wang, Y., H. M. Curry, B. S. Zwilling, and W. P. Lafuse. 2005. Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells. J. Immunol. 174: 5687-5694. (Pubitemid 40593211)
38. Simmons, D. P., D. H. Canaday, Y. Liu, Q. Li, A. Huang, W. H. Boom, and C. V. Harding. 2010. Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9. J. Immunol. 185: 2405-2415.
39. Singh, P. P., C. LeMaire, J. C. Tan, E. Zeng, and J. S. Schorey. 2011. Exosomes released from M. tuberculosis infected cells can suppress IFN-g mediated activation of naïve macrophages. PLoS ONE 6: e18564.
40. El Kasmi, K. C., J. E. Qualls, J. T. Pesce, A. M. Smith, R. W. Thompson, M. Henao-Tamayo, R. J. Basaraba, T. König, U. Schleicher, M. S. Koo, et al. 2008. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 9: 1399-1406.
41. Das, P., A. Lahiri, A. Lahiri, and D. Chakravortty. 2010. Modulation of the arginase pathway in the context of microbial pathogenesis: a metabolic enzyme moonlighting as an immune modulator. PLoS Pathog. 6: e1000899.
42. Arko-Mensah, J., E. Julián, M. Singh, and C. Fernández. 2007. TLR2 but not TLR4 signalling is critically involved in the inhibition of IFN-gamma-induced killing of mycobacteria by murine macrophages. Scand. J. Immunol. 65: 148-157. (Pubitemid 46174922)
43. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175: 1111-1122.
44. Denis, M. 1991. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell. Immunol. 132: 150-157.
45. Herbst, S., U. E. Schaible, and B. E. Schneider. 2011. Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis. PLoS ONE 6: e19105.
46. Morris, S. M., Jr. 2010. Arginine: master and commander in innate immune responses. Sci. Signal. 3: pe27.
47. Nozaki, Y., Y. Hasegawa, S. Ichiyama, I. Nakashima, and K. Shimokata. 1997. Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages. Infect. Immun. 65: 3644-3647. (Pubitemid 27398119)
48. Tjärnlund, A., E. Guirado, E. Julián, P. J. Cardona, and C. Fernández. 2006. Determinant role for Toll-like receptor signalling in acute mycobacterial infection in the respiratory tract. Microbes Infect. 8: 1790-1800. (Pubitemid 44128881)
49. Triantafilou, M., F. G. Gamper, R. M. Haston, M. A. Mouratis, S. Morath, T. Hartung, and K. Triantafilou. 2006. Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J. Biol. Chem. 281: 31002-31011. (Pubitemid 44582155)
50. Zanoni, I., R. Ostuni, L. R. Marek, S. Barresi, R. Barbalat, G. M. Barton, F. Granucci, and J. C. Kagan. 2011. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 147: 868-880.
51. Stuart, L. M., J. Deng, J. M. Silver, K. Takahashi, A. A. Tseng, E. J. Hennessy, R. A. Ezekowitz, and K. J. Moore. 2005. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J. Cell Biol. 170: 477-485. (Pubitemid 41126946)
52. Barbalat, R., L. Lau, R. M. Locksley, and G. M. Barton. 2009. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat. Immunol. 10: 1200-1207.
53. Cole, L. E., K. A. Shirey, E. Barry, A. Santiago, P. Rallabhandi, K. L. Elkins, A. C. Puche, S. M. Michalek, and S. N. Vogel. 2007. Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages. Infect. Immun. 75: 4127-4137. (Pubitemid 47206312)
54. Qualls, J. E., G. Neale, A. M. Smith, M. S. Koo, A. A. DeFreitas, H. Zhang, G. Kaplan, S. S. Watowich, and P. J. Murray. 2010. Arginine usage in mycobacteria-infected macrophages depends on autocrine-paracrine cytokine signaling. Sci. Signal. 3: ra62.
55. Chan, J., X. D. Fan, S. W. Hunter, P. J. Brennan, and B. R. Bloom. 1991. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect. Immun. 59: 1755-1761.
56. Sibley, L. D., S. W. Hunter, P. J. Brennan, and J. L. Krahenbuhl. 1988. Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages. Infect. Immun. 56: 1232-1236.
57. Fabri, M., and R. L. Modlin. 2009. A vitamin for autophagy. Cell Host Microbe 6: 201-203.
58. Liu, P. T., S. Stenger, H. Li, L. Wenzel, B. H. Tan, S. R. Krutzik, M. T. Ochoa, J. Schauber, K. Wu, C. Meinken, et al. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773.
59. Huynh, K. K., S. A. Joshi, and E. J. Brown. 2011. A delicate dance: host response to mycobacteria. Curr. Opin. Immunol. 23: 464-472.
60. Bouley, D. M., N. Ghori, K. L. Mercer, S. Falkow, and L. Ramakrishnan. 2001. Dynamic nature of host-pathogen interactions in Mycobacterium marinum granulomas. Infect. Immun. 69: 7820-7831. (Pubitemid 33086613)
61. Roux, A. L., A. Ray, A. Pawlik, H. Medjahed, G. Etienne, M. Rottman, E. Catherinot, J. Y. Coppée, K. Chaoui, B. Monsarrat, et al. 2011. Overexpression of proinflammatory TLR-2-signalling lipoproteins in hypervirulent mycobacterial variants. Cell. Microbiol. 13: 692-704.
62. Stead, W. W., J. W. Senner, W. T. Reddick, and J. P. Lofgren. 1990. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N. Engl. J. Med. 322: 422-427. (Pubitemid 20059510)